The studies on the characterization of LM autoantibodies reacting against the hepatic CYP-1A2 regarded essentially adults suffering from hydralazine-induced AIH [17] or children and adults affected by AIH as part of APS-1 [9–16]. This evidence concerns the gene CYP1A2 and Autoimmune polyendocrinopathy type 1.